| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Guest Access | Sign In via User Name/Password
|
|
|
|||||||
Guest Access | Sign In via User Name/Password |
|||||||||
* From the Department of Internal Medicine, Sint Franciscus Gasthuis, Rotterdam, The Netherlands.
Correspondence to: Stefan Sleijfer, MD, PhD, Department of Internal Medicine, Sint Franciscus Gasthuis, Kleiweg 500, 3045 PM Rotterdam, The Netherlands; e-mail: sleijfer{at}hotmail.com
The cytotoxic agent bleomycin is feared for its induction of sometimes fatal pulmonary toxicity, also known as bleomycin-induced pneumonitis (BIP). The central event in the development of BIP is endothelial damage of the lung vasculature due to bleomycin-induced cytokines and free radicals. Ultimately, BIP can progress in lung fibrosis. The diagnosis is established by a combination of clinical symptoms, radiographic alterations, and pulmonary function test results, while other disorders resembling BIP have to be excluded. Pulmonary function assessments most suitable for detecting BIP are those reflecting lung volumes. The widely used transfer capacity of the lungs for carbon monoxide appeared recently not to be specific when bleomycin is used in a polychemotherapeutic regimen. There are no proven effective treatments for BIP in humans, although corticosteroids are widely applied. When patients survive BIP, they almost always recover completely with normalization of radiographic and pulmonary function abnormalities. This review focuses on BIP, especially on the pathogenesis, risk factors, and its detection.
Key Words: bleomycin • pneumonitis • pulmonary toxicity
This article has been cited by other articles:
|
|
 |
|
  M. C. B. Godoy, D. Nonaka, B. G. Raphael, and I. Vlahos Diffuse Ground-Glass Opacities in a Patient With Hodgkin Lymphoma and Progressive Respiratory Failure Chest, July 1, 2008; 134(1): 207 - 212. [Full Text] [PDF]
|
|
|
|
 |
|
 K. Kawai, S. Ando, S. Hinotsu, T. Oikawa, N. Sekido, N. Miyanaga, T. Shimazui, and H. Akaza Completion and Toxicity of Induction Chemotherapy for Metastatic Testicular Cancer: An Updated Evaluation of Japanese Patients Jpn. J. Clin. Oncol., July 1, 2006; 36(7): 425 - 431. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Kimura, Y. Ishii, K. Yoh, Y. Morishima, T. Iizuka, T. Kiwamoto, Y. Matsuno, S. Homma, A. Nomura, T. Sakamoto, et al. Overexpression of the Transcription Factor GATA-3 Enhances the Development of Pulmonary Fibrosis Am. J. Pathol., July 1, 2006; 169(1): 96 - 104. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. Joos and M. Tamm Breakdown of Pulmonary Host Defense in the Immunocompromised Host: Cancer Chemotherapy Proceedings of the ATS, December 1, 2005; 2(5): 445 - 448. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W. G. Martin, K. M. Ristow, T. M. Habermann, J. P. Colgan, T. E. Witzig, and S. M. Ansell Bleomycin Pulmonary Toxicity Has a Negative Impact on the Outcome of Patients With Hodgkin's Lymphoma J. Clin. Oncol., October 20, 2005; 23(30): 7614 - 7620. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Nakatani-Okuda, H. Ueda, S.-i. Kashiwamura, A. Sekiyama, A. Kubota, Y. Fujita, S. Adachi, Y. Tsuji, T. Tanizawa, and H. Okamura Protection against bleomycin-induced lung injury by IL-18 in mice Am J Physiol Lung Cell Mol Physiol, August 1, 2005; 289(2): L280 - L287. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. M. Arnaboldi, M. J. Behr, and D. W. Metzger Mucosal B Cell Deficiency in IgA-/- Mice Abrogates the Development of Allergic Lung Inflammation J. Immunol., July 15, 2005; 175(2): 1276 - 1285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 V. Garipidou, S. Vakalopoulou, E. Zafiriadou, V. Kaloutsi, K. Tziomalos, and V. Perifanis Uncommon manifestation of bleomycin-induced pulmonary toxicity in a patient with Hodgkin's disease Ann. Onc., March 1, 2005; 16(3): 514 - 515. [Full Text] [PDF]
|
|
|
|
 |
|
 T. Genovese, S. Cuzzocrea, R. Di Paola, E. Mazzon, C. Mastruzzo, P. Catalano, M. Sortino, N. Crimi, A. P. Caputi, C. Thiemermann, et al. Effect of rosiglitazone and 15-deoxy-{Delta}12,14-prostaglandin J2 on bleomycin-induced lung injury Eur. Respir. J., February 1, 2005; 25(2): 225 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. S. Andrade, K. A. Kesler, J. L. Wilson, J. A. Brooks, B. D. Reichwage, K. M. Rieger, L. H. Einhorn, and J. W. Brown Short- and Long-Term Outcomes after Large Pulmonary Resection for Germ Cell Tumors After Bleomycin-Combination Chemotherapy Ann. Thorac. Surg., October 1, 2004; 78(4): 1224 - 1228. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Kimura, Y. Ishii, Y. Morishima, A. Shibuya, K. Shibuya, M. Taniguchi, M. Mochizuki, A. E. Hegab, T. Sakamoto, A. Nomura, et al. Treatment with {alpha}-Galactosylceramide Attenuates the Development of Bleomycin-Induced Pulmonary Fibrosis J. Immunol., May 1, 2004; 172(9): 5782 - 5789. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Steiger, L. Bubendorf, M. Oberholzer, M. Tamm, and J.D. Leuppi Ciprofloxacin-induced acute interstitial pneumonitis Eur. Respir. J., January 1, 2004; 23(1): 172 - 174. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. W. Moore, J. McKoy, R. Del Valle, D. Armstrong, E. M. Bernard, N. Katz, and R. E. Gordon Fungal Cell Wall Septation and Cytokinesis Are Inhibited by Bleomycins Antimicrob. Agents Chemother., October 1, 2003; 47(10): 3281 - 3289. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF]
|
|
|
|
|
|
M. Ando, Y. Murakami, F. Kojima, H. Endo, H. Kitasato, A. Hashimoto, H. Kobayashi, M. Majima, M. Inoue, H. Kondo, et al. Retrovirally Introduced Prostaglandin D2 Synthase Suppresses Lung Injury Induced by Bleomycin Am. J. Respir. Cell Mol. Biol., May 1, 2003; 28(5): 582 - 591. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Huang, G. Wang, D. S. Phelps, H. Al-Mondhiry, and J. Floros Combined SP-A-bleomycin effect on cytokines by THP-1 cells: impact of surfactant lipids on this effect Am J Physiol Lung Cell Mol Physiol, July 1, 2002; 283(1): L94 - L102. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
